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ABSTRACT 1 
 2 
Objective:  3 
To investigate the effect of an 8 week group based cognitive behaviour therapy 4 
intervention on change in weight and other weight related variables, change in 5 
physical activity and change in health and well being compared to individualised 6 
dietetic treatment or giving information only 7 
 8 
Design:  9 
A randomised control trial with an 8-week intervention period – two intervention 10 
groups, a group based cognitive behaviour therapy intervention, Fat Booters Inc – 11 
(FBI) and individualised dietetic treatment (IDT) and control group receiving an 12 
information booklet only (BO). Intervention for 8 weeks with monthly follow-up to 6 13 
months and further follow-up at 12 months, conducted in real practice setting. 14 
 15 
Subjects: 16 
A total of 176 adults with body mass index (BMI) > 27kg/m2, mean (±SD) age 48±13 17 
years, mean BMI 34±5.5 kg/m2. 18 
 19 
Main Outcome Measures: 20 
Weight, percent body fat, waist circumference, physical activity, health status, self-21 
efficacy and satisfaction with life were measured at baseline, 3, 6 and 12 months. 22 
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 1 
Results: 2 
A statistically significant difference between groups was observed for weight change 3 
over time (p = 0.05). The change in weight (mean ± se) for the FBI group was 4 
significantly greater than the BO group at 6 and 12 months (-2.8 ± 0.7 compared to –5 
1.0 ± 0.6 kg, p<0.05 and –2.9 ± 0.9 compared to +0.5 ± 0.9 kg, p<0.005, 6 
respectively). Change in weight in the IDT group did not differ from the FBI group at 7 
any time point. For all groups, waist circumference was significantly less than 8 
baseline at all time points (p<0.001). Significant differences in self-efficacy were 9 
observed over time (p=0.02), with both intervention groups having greater self-10 
efficacy than the BO group. Significant drop-outs occurred over time for all three 11 
groups. 12 
 13 
Conclusions 14 
A cognitive behaviour based intervention was more effective than providing 15 
information alone and as effective as intensive individualised dietetic intervention in 16 
weight loss and improvements in self-efficacy. The FBI group was more cost effective 17 
to conduct in a real practice setting.18 
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INTRODUCTION 1 
 2 
Overweight and obesity have grown to be one of the major public health problems of 3 
the 21st century, both in developed and developing countries1. Recent national data 4 
indicate that approximately 60% of the adult Australian population is overweight or 5 
obese2.   6 
 7 
Obesity per se has now been recognised as an independent chronic condition, which 8 
contributes over 4% to the burden of disease in Australia3. Combined with lack of 9 
physical activity, which contributes 7%, this is an overall contribution of 11%. The true 10 
cost of this burden of disease has been estimated at A$680-1239m from the impact 11 
of obesity and overweight alone4. 12 
 13 
Intervention studies for the management of overweight and obesity have shown 14 
disappointing results long term, however a review of many studies has shown 15 
confounding due to poor study design5,6. On the other hand, lifestyle interventions 16 
resulting in weight losses of 3-5 kg, have been effective in the prevention or delay of 17 
disease7,8,9. Intervention studies now focus on small, sustainable losses of weight in 18 
the order of 5-10%10. 19 
 20 
Evidence based guidelines for weight management recommend energy restriction, 21 
combined with increase in exercise and behaviour therapy11,12. Failure of patients 22 
complying with prescriptive medical advice has been linked to the style of treatment. 23 
Disease management styles, which centre around the patient and their goals have 24 
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resulted in better adherence to treatment protocols, reduced morbidity and improved 1 
quality of life13.  2 
 3 
Use of chronic disease self-management and patient centred care approaches is also 4 
important in the management of weight. These approaches include shared goal 5 
setting, developing action plans, teaching skills and regular follow-up14.  6 
 7 
Studies demonstrating success in weight loss are usually conducted in tightly 8 
controlled clinical trial settings. Most have invested large resources in the form of 9 
financial incentives for attending programs15, for meal replacements16 or for 10 
medications in drug trials17. When these methods are translated to real practice 11 
settings the results are often disappointing, calling experts to recommend more 12 
‘effectiveness’ rather than ‘efficacy’ based research1. Effectiveness research focuses 13 
on the reach, efficacy, adoption, implementation and maintenance (RE-AIM) of a 14 
program in real world settings18. This research is conducted so that its results have 15 
external validity, generalisability and sustainability in real practice.  Unlike efficacy 16 
interventions, effectiveness based research (i) uses heterogeneous, representative 17 
samples with few exclusion criteria; (ii) uses brief feasible interventions which are 18 
adaptable to different settings; (iii) uses a variety of staff with competing demands to 19 
implement the interventions; and (iv) focuses on maintaining the ability of the setting 20 
to continue the intervention as standard practice. The current study was designed to 21 
reflect real clinical practice. 22 
 23 
This study aimed to demonstrate that (1) group based cognitive behaviour therapy 24 
intervention is more effective at reducing weight and other weight related variables, 25 
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increasing physical activity and improving health and well-being than individualised 1 
dietetic treatment or giving information only, at 3 months, and (2) group based 2 
cognitive behaviour therapy intervention is more effective at maintaining these 3 
changes than individualised dietetic treatment or giving information only, at 12 4 
months. 5 
6 
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METHODS 1 
 2 
Study Design 3 
The study was a randomised-controlled 12-month trial conducted between two 4 
tertiary hospitals (public and private) between February 2002 and July, 2003. The 5 
trial replaced the previous hospital outpatient service for weight management at the 6 
public hospital but was a new service at the private facility, which previously had not 7 
provided any ambulatory care services. A project manager (TD) was employed to 8 
manage the recruitment, randomisation of subjects and maintenance of data. A total 9 
of thirteen dietitians and nutrition staff employed by the two sites, collected patient 10 
data and provided the group facilitation, dietetic intervention and follow-up. A group 11 
facilitation manual was provided for the groups and all facilitators were trained prior to 12 
the trial commencing. A standard protocol was developed for use in the individualised 13 
dietetic treatment. 14 
 15 
Figure 1 shows the outline of the study design. Outcome data were collected at 16 
baseline, 3 months, 6 months and 12 months. The study received ethical approval 17 
from the participating institutions’ ethics committees. All subjects received written and 18 
oral information about the study prior to consenting.  19 
 20 
Study Participants 21 
Overweight and obese men and women (BMI ≥ 27kg/m ²) were recruited for 22 
participation in the study from current hospital referrals and by advertising in local 23 
community newspapers. Exclusion criteria included body mass index (BMI) less than 24 
27 kg/m², less than 18 years of age, from non-English speaking background requiring 25 
   8 
 
an interpreter or cognitive impairment. Potential participants were not excluded based 1 
on medical condition(s) or medication(s). 2 
 3 
Randomisation 4 
After screening for exclusion criteria and following informed consent, participants 5 
were randomised by the project manager, using a random number table, into one of 6 
three intervention groups at one of two hospital sites. The allocation ratio for the two 7 
hospital sites (public and private) was 2:1 due to available resources for 8 
implementing the intervention. 9 
 10 
Dietary Interventions 11 
Participants in all three groups were required to purchase a nutrition resource booklet 12 
based on cognitive behaviour therapy principles19. Participants assigned to the Fat 13 
Booters Incorporated (FBI) group attended an eight-week (one and a half hours per 14 
week for six weeks with follow-up at 8 weeks) lifestyle behaviour management group, 15 
with 10-12 participants per group.  16 
 17 
The group program used a tri-phasic design involving knowledge and skill 18 
development, cognitive behaviour therapy and relapse prevention with a focus on 19 
improvements in self-concept, self-efficacy and skills mastery. It emphasised 20 
empowerment, development of self-efficacy and skills, with a non-directive approach 21 
taken by facilitators. While information was available about diet and exercise, it was 22 
up to individuals if they acted on this information in making changes to their lifestyle. 23 
 24 
   9 
 
Following completion of the program, FBI participants attended a follow-up visit at 1 
week 8 and then monthly until 6 months. Attendance at each session during the initial 2 
intervention and at follow-up was recorded. 3 
 4 
Participants assigned to the individualised dietetic treatment (IDT) group, were 5 
provided with individualised weekly contact with a dietitian for eight weeks. This 6 
included an initial nutrition assessment, provision of an individualised diet prescription 7 
(aiming to achieve a weight loss of 0.5-1kg/week), and an exercise prescription (20 – 8 
30 minutes of accumulated exercise most days of the week). IDT participants 9 
attended monthly follow-up visits from week 8 to 6-months. Attendance at each 10 
session during the initial intervention and at follow-up was recorded. If a patient was 11 
unable to attend the clinic for an appointment, an attempt was made to provide the 12 
intervention via the telephone for that appointment. 13 
 14 
Participants in the booklet only (BO) group acted as the control group and were 15 
provided with no further nutritional advice other than the nutrition resource booklet. 16 
 17 
Outcome Measures 18 
All outcome measures for all participants, in all groups, were assessed at baseline, 3 19 
months, 6 months and 12 months. Weight and body composition were measured 20 
using foot-to-foot bioelectrical impedance analysis (Model TBF-410, Tanita Inc., 21 
Tokyo, Japan). Weight and percent body fat were measured without shoes or heavy 22 
clothing to the nearest 0.1kg and 0.1%, respectively. Height was measured by a fixed 23 
stadiometer, without shoes, to the nearest 0.5cm. Body mass index (BMI) was 24 
calculated from weight in kilograms divided by height in meters squared. Waist 25 
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circumference was measured with a non-expandable tape at the point of the 1 
umbilicus, to the nearest 0.5 cm.  2 
 3 
Physical activity level was assessed using the short format International Physical 4 
Activity Questionnaire (IPAQ)20. The questionnaire collected information on the 5 
number of days and amount of time spent (when greater than 10mins) on vigorous 6 
activities, moderate activities and walking in the past 7 days. Participants were 7 
categorised as ‘sufficiently active’ or ‘not sufficiently active’. Sufficient activity was 8 
defined as five or more days of moderate activity or walking of at least 30 minutes per 9 
day (150 minutes per week) or three or more days of vigorous activity of at least 20 10 
minutes per day. These criteria are based on national and international 11 
recommendations for the minimum amount of physical activity required for good 12 
health21. The reported test-re-test reliability Spearman correlation coefficient was 13 
0.80 and median criterion validity correlation against an accelerometer was 0.3020.  14 
 15 
Health status was measured using the General Health Questionnaire (GHQ-12)22. 16 
The GHQ-12 is a 12-item scale for measuring non-psychotic disorders. The 17 
questionnaire is usually used as a continuous scale (0 – 12) with 0 indicating good 18 
health. However, due to non-normal distribution of this variable in our study 19 
participants, scores on the GHQ-12 were categorised in to two categories – good 20 
health (0) and not in good health (greater than or equal to 1). Self-efficacy was 21 
assessed using the Generalised Self-Efficacy Scale (GSES), a 10-item, four-point 22 
Likert scale23. Overall scores range from 10 – 40, with a higher score indicating a 23 
higher level of self-efficacy. General well being was measured using the Satisfaction 24 
with Life Scale (SWLS)24. The SWLS is a five-item, seven-point Likert scale. 25 
   11 
 
Individual items are summed for an overall score ranging from 5 to 35, with a higher 1 
score indicating better well-being. The SWLS has been shown to be a reliable and 2 
valid measure of overall quality of life. Psychometric testing of the GHQ-12, GSES 3 
and SWLS has indicated high level of agreement (Cronbach’s alpha = 0.82 to 4 
0.93)22,25,26. 5 
 6 
Statistical Analysis 7 
General descriptive and bivariate statistical analyses were carried out using SPSS for 8 
Windows (Version 11.00, 2003, SPSS Inc., Chicago, IL, USA). Continuous variables 9 
were tested for normal distribution. Data are presented as means ± sd or se for 10 
continuous variables and counts (percentages) for categorical variables. Analyses 11 
were carried out on an intention-to-treat basis. One-way analysis of variance 12 
(ANOVA) and Fisher’s exact test were used to determine whether dietary intervention 13 
groups differed at baseline and whether differences existed between those subjects 14 
for whom complete data was obtained and those who had missing data (incomplete 15 
or drop-outs). To examine changes in intervention groups over time and to maximise 16 
the amount of data that were used in the analysis the following analysis was 17 
completed; repeated measures analysis of variance regression models for 18 
continuous variables and repeated measures logistic regression models for 19 
categorical variables, using a generalised estimating equations approach (SUDAAN 20 
statistical package, Version 7.5, 1997, NC, USA). The significance was set at P<0.05. 21 
 22 
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Results 1 
 2 
A total of two hundred and eight (n=208) participants were assessed for eligibility 3 
between January and July 2002 (Figure 1). Seventeen subjects, with BMI<27 kg/m2 4 
(n=11) and cognitive impairment or lack of language skills (n=6) were excluded. One 5 
hundred and ninety one (191) participants were randomised into the three intervention 6 
groups of the study, however a small number (n=14) withdrew consent following 7 
randomisation and before baseline data were collected. Figure 1 shows the numbers of 8 
participants at enrolment, allocation, and follow-up in each group. The intention to treat 9 
analysis using Sudaan allows for the management of missing data ?????? something 10 
here Marina? 11 
  12 
 13 
Baseline characteristics of participants did not differ significantly between the intervention 14 
groups (Table 1). Groups also did not differ with respect to employment status, highest 15 
level of education, living situation, previous weight loss and dieting at commencement of 16 
the study. Characteristics of participants differed slightly between the two hospital sites – 17 
participants at the public hospital had a significantly higher BMI (Fisher’s Exact test p = 18 
0.02) and waist circumference (Fisher’s Exact test p = 0.04) than participants attending 19 
the private hospital.  20 
 21 
Table 2 shows the number of participants in each intervention group for whom complete 22 
data at all four time points were collected, those for whom incomplete data were 23 
collected (two or three time points) and those who were classed as true drop-outs, for 24 
whom only baseline data were available.  25 
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 1 
There was a significant difference in the amount of data available for participants 2 
between intervention groups (Fisher’s Exact test, p = 0.01). A greater number of 3 
participants in the BO group than expected were dropout, while more participants in the 4 
IDT group than expected had complete data. The amount of data available for 5 
participants did not differ significantly between hospital sites. There were significant 6 
differences in the data available for participants for gender, age, BMI and percent body 7 
fat. Significantly more females than expected were drop outs, compared to males 8 
(Fisher’s Exact test, p = 0.01). Drop-outs tended to be younger than participants for 9 
whom complete and incomplete data were available (F(2,158)= 3.248, p = 0.04). 10 
Participants who dropped out had a higher BMI (36.5 ± 6.1 vs 33.8 ± 5.4 kg/m2; F(2,173)= 11 
4.065, p=0.019) and percent body fat (44.1 ± 6.3 vs 39.4 ± 6.9%; F(2,164)= 6.331, 12 
p=0.002). 13 
 14 
Weight, Body Mass Index, Percent Body Fat and Waist Circumference 15 
Changes in weight, BMI, body fat and waist circumference between the three groups 16 
over the four time points are shown in Table 3. A statistically significant difference 17 
between the groups over time was evident for change in weight (Wald F6 = 2.13, p = 18 
0.05). This was reflected in a difference in change in BMI between groups, which 19 
approached statistical significance (Wald F6 = 2.1, p = 0.06). Change in weight was 20 
compared to baseline and compared to FBI group. Significant differences in change in 21 
weight were observed between the BO and FBI group at 3 months (p = 0.05) and 12 22 
months (p = 0.005). Change in weight in the IDT group did not differ to the FBI group at 23 
any of the time points.  24 
 25 
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Change in percent body fat and waist circumference did not differ between the three 1 
groups over the 12 months. For all participants, waist circumference was significantly 2 
lower than baseline level at each of the follow-up time points (p < 0.001) I could not find 3 
this on the Sudaan printout, it all looks non-significant to me! however percent body fat 4 
was not significantly different from baseline at 3 months, 6 months or 12 months.  5 
 6 
Physical Activity Levels 7 
There appeared to be differences in the proportion of patients who were sufficiently 8 
active between the intervention groups over time, although not statistically significant 9 
(Wald F6 = 11.46, p = 0.075). Table 4 shows the odds of being sufficiently active in the 10 
IDT and BO groups at 3 months, 6 months and 12 months, relative to baseline and the 11 
FBI group. Relative to the FBI group, the odds of being sufficiently active at 3 months 12 
compared to baseline were 0.27 (95% CI 0.07, 1.02) times lower in the IDT group 13 
(p=0.053) and 0.19 (95%CI 0.05, 0.77) times lower in the BO group (p=0.021). There 14 
were no further significant differences in physical activity level at 6 months or 12 months. 15 
 16 
 17 
Health and Wellbeing Scales 18 
Health status and general wellbeing did not differ between groups over time. Significant 19 
differences were observed for self-efficacy score between groups over the 12 months 20 
(Wald F6 = 2.57, p = 0.02). Table 5 shows the mean scores for the three groups. Mean 21 
self-efficacy score for BO group differed significantly to FBI group at 3 months (p = 0.01) 22 
and 12 months (p < 0.01). 23 
 24 
 25 
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Discussion 1 
Obesity is an increasing problem worldwide, but particularly in Australia, where calls for 2 
government action to address the problem are evident10. Few interventions, where 3 
weight loss is sustained and which address lifestyle issues, have been designed in real 4 
practice settings or have been evaluated for long enough periods1.  5 
 6 
Our study was designed to implement recent evidence based guidelines for the 7 
management of overweight and obesity in a real practice environment. We have 8 
demonstrated that an 8-week intensive lifestyle intervention, with monthly follow-up to 6 9 
months could be conducted in a real practice setting and produce modest results of 3kg 10 
weight loss, which were sustained over 12 months.  11 
Our previous work also indicated greater weight losses in a tightly controlled research 12 
setting, however these losses were not sustained over time27. Other studies have 13 
indicated that the effects of lifestyle interventions are often modest7,9. A randomised trial, 14 
which assigned 423 overweight people to a structured commercial weight loss program 15 
or self help program, observed mean (±sd) weight loss of 4.3(± 6.1)kg compared to 1.3(± 16 
6.1)kg at 12 months, and 2.9(± 6.5)kg compared to 0.2 ± 6.5)kg at 2 years. Participants 17 
in the structured weight loss arm received incentives in the form of vouchers for the cost 18 
of the commercial program and had contact with the researchers every one to two weeks 19 
over the two-year period15.  20 
 21 
In our study, there was no significant difference in weight loss between the two 22 
intervention groups over the 12 months. There was a trend however for the FBI group to 23 
maintain weight loss compared to the other 2 groups. It is therefore possible that the 24 
cognitive behaviour therapy program used in the group provided better strategies for 25 
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maintaining healthy behaviours long term. Leibbrand et al28 found that weight loss 1 
following a 10-week behavioural intervention was sustained after 18 months, with and 2 
without follow-up support. They propose that the CBT strategies learned and reinforced 3 
in the 10-week behavioural intervention were sufficient to sustain weight loss without 4 
support for the follow-up period. 5 
 6 
The FBI group-based program also took a patient centred approach, offering a structured 7 
way for participants to become expert in managing their lifestyle issues and chronic 8 
disease(s).  Self efficacy is enhanced when patients have a collaborative plan for self 9 
care which includes an assessment of beliefs, barriers and supports; a personal action 10 
plan that identifies both goals and barriers; and an active follow-up plan that monitors 11 
progress, while providing support for the patient throughout14.  12 
 13 
The effectiveness of the intervention in preventing further weight gain is evident in both 14 
the intervention groups compared to the control. Health authorities indicate that a mean 15 
weight loss of 1 kg in the Australian population would have major impact on health 16 
costs29. Other studies have shown the effectiveness of dietetic intervention on minimising 17 
or delaying the costs of drug and other treatment in cardiovascular disease30 and 18 
diabetes31. This study did not attempt to assess cost effectiveness using health 19 
economics modelling but it is clearly evident that implementation of the FBI program in a 20 
real practice setting is more cost efficient than standard individual dietetic counselling, 21 
while at the same time achieving similar outcomes over a 12-month period.  22 
 23 
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Cost to replicate  1 
While there appeared to be no difference between the FBI and the IDT groups in weight 2 
outcomes, the group-based intervention was able to manage more overweight patients 3 
over time. A conservative estimate of the amount of time required to conduct the FBI 4 
group, including room set up and documentation was about 3 hours/session. The FBI 5 
program accommodated 10-12 participants, over 6-8 weeks. It has continued to run at 6 
least 6 sessions per year, so a minimum of 60-72 overweight people can be 7 
accommodated per year. For the same time frame of a 3-hour clinic, the IDT program, 8 
which includes a 1-hour initial individual consultation, followed by seven 20-minute 9 
weekly review sessions and 4 monthly follow-up sessions of 20 minutes, can manage 10 
only 25 people per year.  It is estimated that the cost of providing dietetic service for 11 
weight management would range from $A253-415 per patient on an individual basis 12 
compared to $1A06-117 per patient on a group basis.  13 
 14 
There were a number of limitations in this study. Firstly there was a large attrition rate, 15 
particularly from the BO group, where only 37% of the initial sample had complete data.  16 
In a review of randomised control trials with at least 12-month follow-up on advice on 17 
low-fat diets for obesity, 40% losses to follow-up were demonstrated with only 20% of 18 
subjects remaining in one study, which was extended to 18 months32. While care is 19 
required in interpreting the results in such studies of weight loss, the high dropout rate is 20 
not an unusual phenomenon. Every attempt was made to contact all participants at 12 21 
months, unless consent had been withdrawn. 22 
 23 
There were also significant differences in gender, age, BMI and percent body fat 24 
between participants with complete data, missing data and dropouts, which have 25 
  
  18 
 
decreased the representativeness of our sample. To account for the missing data, results 1 
were analysed on an intention-to-treat basis using a generalised estimating equations 2 
approach.  3 
 4 
Secondly the reported levels of sufficient physical activity by participants at baseline 5 
(57.9%) were considerably greater than the general Australian population (45.2%)33. This 6 
may be due to over reporting by participants in this study or due to the potential over 7 
estimation of physical activity level using the IPAQ, which has been reported in other 8 
studies34. The measurement error may have attenuated the true effect size of physical 9 
activity in this study.  10 
 11 
Finally the study did not measure other clinical endpoints such as blood sugars, lipids or 12 
other markers of disease, so no conclusions can be drawn on the impact of the weight 13 
loss and increases in physical activity on improvements in health outcomes other than 14 
weight. 15 
 16 
Study strengths include being conducted under real world clinical practice conditions. 17 
That is, minimal inclusion and exclusion criteria were applied, incentives were not 18 
provided and dietetic staff provided the interventions within normal workplace 19 
requirements. This is in contrast to previous studies, which have provided participants 20 
with enticing incentives to maintain involvement15 or applied stringent eligibility 21 
criteria16,28, which limit generalisability of the results.  22 
 23 
In conclusion, a group-based lifestyle program using cognitive behaviour therapy was not 24 
more effective at reducing weight, increasing physical activity or improving health and 25 
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wellbeing at 3 months, than intensive individualised counselling or providing information 1 
only. The FBI program was more effective at achieving weight loss and improving self-2 
efficacy at 12 months compared to the booklet only group. Both the FBI and IDT groups 3 
sustained weight losses of 2-3kg at 12 months. The FBI program can be applied to both 4 
a public and private ambulatory setting and the structured nature of the FBI program and 5 
the training manual provided can easily be learnt by health professional and is flexible 6 
enough to be delivered by a range of practitioners. Added to this, we have shown that 7 
this type of program is possible to conduct under real work conditions, is more cost 8 
efficient and provides at least as good outcomes over 12 months as an intensive 9 
individualised approach.  10 
 11 
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Figure 1. Study design and intention to treat analysis protocol 1 
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Table 1 Baseline characteristics of participants by intervention group 1 
 FBI IDT BO 
N  57 65 54 
Age (y) 49 ± 13 48 ± 13 47 ± 14 
Gender (M:F) 19:38 16:49 12:42 
Weight (kg) 94.6 ±16.8 95.4 ± 20.7 101.6 ± 18.4 
BMI (kg/m2) 33.7 ± 4.6 34.2 ± 5.9 35.8 ± 6.2 
Body Fat (%) 39.6 ± 6.4 41.4 ± 7.1 41.9 ± 7.4 
Waist (cm) 111.5 ± 13.3 111.5 ± 16.2 114.3 ± 17.3 
GHQ-12     
 Good Health 24 (42.1%) 27 (41.5%) 22 (40.7%) 
  Not Good Health 33 (57.9%) 38 (58.5%) 32 (59.3%) 
GSES 31 ± 5 30 ± 5 31 ± 6 
SWLS 22 ± 8 20 ± 7 22 ± 7 
Activity        
 Insufficient 22 (40.0%) 27 (41.5%) 21 (40.4%) 
 Sufficient 33 (60.0%) 38 (58.5%) 31 (59.6%) 
Data are mean ± standard deviation or n(%). 2 
3 
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Table 2 Amount of available data on participants by intervention group 1 
 FBI IDT BO 
N  57 65 54 
Complete Data 26 (45.6%) 44 (67.7%) 20 (37.0%) 
Incomplete Data† 16 (28.1%) 10 (15.4%) 14 (25.9%) 
Drop out‡ 15 (26.3%) 11 (16.9%) 20 (37.0%) 
† Missing data for one or two time points (at month 3, 6 or 12) 2 
‡ Baseline data only available 3 
 4 
5 
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Table 3 Change in anthropometric variables over time 1 
 3 Months 6 Months 12 Months 
Weight (kg)    
 FBI -1.9 (0.5) -2.8 (0.7) -2.9 (0.9) 
 IDT -2.6 (0.4) -2.6 (0.5) -1.8 (0.8) 
 BO1 -1.4 (0.5) -1.0 (0.6) 0.5 (0.9) 
BMI (kg/m2)    
 FBI -0.7 (0.2) -1.0 (0.2) -1.0 (0.3) 
 IDT -0.9 (0.1) -0.9 (0.2) -0.6 (0.3) 
 BO2 -0.5 (0.2) -0.4 (0.2) 0.2 (0.3) 
Body Fat (%)    
 FBI -0.2 (0.7) 0.0 (0.5) -0.2 (0.8) 
 IDT -0.4 (0.4) -1.6 (0.5) -1.3 (0.6) 
 BO 0.7 (0.5) -0.4 (0.4) 0.0 (0.5) 
Waist (cm)    
 FBI -3.5 (0.6) -4.3 (0.9) -5.8 (1.2) 
 IDT -4.6 (0.9) -4.8 (1.1) -4.5 (1.1) 
 BO -3.5 (0.9) -4.6 (1.5) -3.1 (1.0) 
Values are mean (standard error) for change from baseline 2 
FBI  Fat Booters Inc group 3 
IDT  Individual Dietetic Intervention group 4 
BO Booklet Only group 5 
1   Overr alll lll   Wald F6 = 2.13, p = 0.05    (Not sure how to report the difference stated in the 6 
text of p<0.05 between FBI and BO at 3 months and p<0.005 at 6 months) 7 
2 Overall Wald F6 = 2.1, p = 0.06  8 
9 
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Table 4 Odds ratio (95% Confidence Interval) of being sufficiently active compared to 1 
baseline 2 
 3 Months 6 Months 12 months 
 FBI 1.00 1.00 1.00 
 IDT 0.27 (0.07, 1.02) 0.62 (0.20, 1.92) 0.73 (0.24, 2.22) 
 BO1 0.19 (0.05, 0.77) 0.47 (0.13, 1.69) 2.15 (0.52, 8.84) 
 3 
1 p=0.021  4 
 5 
 6 
7 
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Table 5 Mean (± standard error) Self-Efficacy Scores  1 
 Baseline 3 Months 6 Months 12 Months 
 FBI 30.7 (0.6) 32.2 (0.8) 30.8 (1.0) 33.0 (0.8) 
 IDT 30.5 (0.6) 31.7 (0.6) 31.6 (0.6) 32.9 (0.6) 
 BO1 30.6 (0.8) 29.6 (1.0) 29.5 (0.9) 29.4 (1.2) 
 2 
1 Wald F6 = 2.57, p = 0.02 (again not sure how to report the difference at 3 montsh of 3 
p=0.01 and 12 months p<0.01, it actually looks like p=0.006) I might not  have the final 4 
sudaan printouts for this and exercise only what Angela had. 5 
 6 
